Publication | Closed Access

Discovery of 5-naphthylidene-2,4-thiazolidinedione derivatives as selective HDAC8 inhibitors and evaluation of their cytotoxic effects in leukemic cell lines

Selective Hdac8 InhibitorsMedicine5-Naphthylidene-2,4-thiazolidinedione DerivativesPharmacological AgentPharmacotherapyAnti-cancer AgentDrug DevelopmentLeukemic Cell LinesPharmacologyRadiation OncologyDrug Discovery